Teva Pharma Stock Options Expiring on 21st of February
| TEVA Stock | USD 21.60 0.53 2.52% |
Teva Pharma's latest option contracts expiring on February 21st 2025 are carrying combined implied volatility of 0.6. The total put volume is at 527, with calls trading at the volume of 252. This yields a 2.09 put-to-call volume ratio. The Teva Pharma option chain provides detailed quote and price information for the current Teva Pharma Industries option contracts. It shows all of Teva Pharma's listed puts, calls, expiration dates, strike prices, and other pricing information.
Teva Pharma Maximum Pain Price Across 2025-02-21 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Teva Pharma close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, Teva Pharma's option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Teva Pharma's stock options are financial instruments that give investors the right to buy or sell shares of Teva Pharma Industries common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Teva stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Teva Pharma's stock price goes up or down, the stock options follow.
At present, Teva Pharma's Total Stockholder Equity is projected to decrease significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 28.6 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 777 M. Teva Pharma Industries In The Money Call Balance
When Teva Pharma's strike price is surpassing the current stock price, the option contract against Teva Pharma Industries stock is said to be in the money. When it comes to buying Teva Pharma's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Teva Pharma Industries are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Teva Current Options Market Mood
Teva Pharma's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Teva Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Most options investors, including buyers and sellers of Teva Pharma's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Teva Pharma's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Teva contract
Base on the Rule 16, the options market is currently suggesting that Teva Pharma Industries will have an average daily up or down price movement of about 0.0375% per day over the life of the 2025-02-21 option contract. With Teva Pharma trading at USD 21.6, that is roughly USD 0.0081. If you think that the market is fully incorporating Teva Pharma's daily price movement you should consider buying Teva Pharma Industries options at the current volatility level of 0.6%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Teva |
Teva Pharma Option Chain
When Teva Pharma's strike price is surpassing the current stock price, the option contract against Teva Pharma Industries stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Teva Pharma's option chain is a display of a range of information that helps investors for ways to trade options on Teva. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Teva. It also shows strike prices and maturity days for a Teva Pharma against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | TEVA250221C00013000 | 0 | 13.0 | 6.9 - 8.6 | 6.9 | In |
Call | TEVA250221C00014000 | 0 | 14.0 | 7.2 - 7.6 | 7.2 | In |
Call | TEVA250221C00015000 | 0 | 15.0 | 6.4 - 7.25 | 6.4 | In |
Call | TEVA250221C00016000 | 0 | 16.0 | 4.4 - 6.55 | 4.4 | In |
Call | TEVA250221C00017000 | 0 | 17.0 | 4.5 - 4.9 | 4.5 | In |
Call | TEVA250221C00018000 | 0 | 18.0 | 2.36 - 3.9 | 2.36 | In |
Call | TEVA250221C00019000 | 0 | 19.0 | 1.94 - 4.0 | 2.98 | In |
Call | TEVA250221C00020000 | 0 | 20.0 | 2.08 - 2.46 | 2.13 | In |
Call | TEVA250221C00021000 | 0 | 21.0 | 1.3 - 2.28 | 1.3 | In |
Call | TEVA250221C00022000 | 0 | 22.0 | 0.0 - 1.82 | 1.82 | |
Put | TEVA250221P00013000 | 0 | 13.0 | 0.0 - 2.14 | 2.14 | |
Put | TEVA250221P00014000 | 0 | 14.0 | 0.0 - 2.15 | 2.15 | |
Put | TEVA250221P00015000 | 0 | 15.0 | 0.0 - 2.16 | 2.16 | |
Put | TEVA250221P00016000 | 0 | 16.0 | 0.0 - 0.58 | 0.58 | |
Put | TEVA250221P00017000 | 0 | 17.0 | 0.12 - 0.16 | 0.11 | |
Put | TEVA250221P00018000 | 0 | 18.0 | 0.22 - 0.74 | 0.22 | |
Put | TEVA250221P00019000 | 0 | 19.0 | 0.4 - 1.2 | 0.37 | |
Put | TEVA250221P00020000 | 0 | 20.0 | 0.0 - 0.84 | 0.66 | |
Put | TEVA250221P00021000 | 0 | 21.0 | 0.0 - 1.43 | 1.43 | |
Put | TEVA250221P00022000 | 0 | 22.0 | 0.0 - 2.37 | 2.37 | In |
Teva Pharma Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Teva Pharma Market Cap Over Time
Market Cap |
| Timeline |
Teva Total Stockholder Equity
Total Stockholder Equity |
|
Teva Pharma Corporate Directors
| Nechemia Peres | Independent Director | Profile | |
| JeanMichel Halfon | Statutory - independent director | Profile | |
| Perry Nisen | Independent Director | Profile | |
| Gerald Lieberman | Independent Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharma Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teva Pharma. If investors know Teva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teva Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.4 | Earnings Share (0.85) | Revenue Per Share | Quarterly Revenue Growth 0.125 | Return On Assets |
The market value of Teva Pharma Industries is measured differently than its book value, which is the value of Teva that is recorded on the company's balance sheet. Investors also form their own opinion of Teva Pharma's value that differs from its market value or its book value, called intrinsic value, which is Teva Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teva Pharma's market value can be influenced by many factors that don't directly affect Teva Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teva Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teva Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teva Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.